Abstract:Nucleic acid-based drugs, such as RNA and DNA drugs, exert their effects at the genetic level. Currently, widely utilized nucleic acid-based drugs include nucleic acid aptamers, antisense oligonucleotides, mRNA, miRNA, siRNA and saRNA. However, these drugs frequently encounter challenges during clinical application, such as poor stability, weak targeting specificity, and difficulties in traversing physiological barriers. By employing chemical modifications of nucleic acid structures, it is possible to enhance the stability and targeting specificity of certain nucleic acid drugs within the body, thereby improving delivery efficiency and reducing immunogenicity. Moreover, utilizing nucleic acid drug carriers can facilitate the transportation of drugs to lesion sites, thereby aiding efficient intracellular escape and promoting drug efficacy within the body. Currently, commonly employed delivery carriers include virus vectors, lipid nanoparticles, polymer nanoparticles, inorganic nanoparticles, protein carriers and extracellular vesicles. Nevertheless, individual modifications or delivery carriers alone are insufficient to overcome numerous obstacles. The integration of nucleic acid chemical modifications with drug delivery systems holds promise for achieving enhanced therapeutic effects. However, this approach also presents increased technical complexity and clinical translation costs. Therefore, the development of nucleic acid drug carriers and nucleic acid chemical modifications that are both practical and simple, while maintaining high efficacy, low toxicity, and precise nucleic acid delivery, has become a prominent research focus in the field of nucleic acid drug development. This review comprehensively summarizes the advancements in nucleic acid-based drug modifica-tions and delivery systems. Additionally, strategies to enhance nucleic acid drug delivery efficiency are discussed, with the aim of providing valuable insights for the translational application of nucleic acid drugs.

Recent progress and application of the tetrahedral framework nucleic acid materials on drug delivery

The Application of Tetrahedral Framework Nucleic Acids as a Drug Carrier in Biomedicine Fields

Tetrahedral framework nucleic acids as an advanced drug delivery system for oligonucleotide drugs

Progress in Biomedical Applications of Tetrahedral Framework Nucleic Acid-Based Functional Systems

Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations

Research Advances of Tetrahedral Framework Nucleic Acid-Based Systems in Biomedicine

Framework Nucleic Acids: A Promising Vehicle for Small Molecular Cargos

Functionalizing Framework Nucleic‐Acid‐Based Nanostructures for Biomedical Application

Pharmaceutical applications of framework nucleic acids

Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation

Recent advances in DNA nanostructure‐enabled drug delivery

Nucleic acid-based drug delivery strategies

Tetrahedral Framework Nucleic Acids and Human Health

Framework Nucleic Acids in Nuclear Medicine Imaging: Shedding Light on Nano–Bio Interactions

Framework Nucleic Acids: Innovative Tools for Cellular Sensing and Therapeutics

Functionalizing tetrahedral framework nucleic acids-based nanostructures for tumor in situ imaging and treatment

Advances in modification and delivery of nucleic acid drugs

Framework Nucleic Acids As Programmable Carrier for Transdermal Drug Delivery.

Application Progress of DNA Nanostructures in Drug Delivery and Smart Drug Carriers

A dynamic DNA tetrahedron framework for active targeting

Application of Programmable Tetrahedral Framework Nucleic Acid-Based Nanomaterials in Neurological Disorders: Progress and Prospects